Eli Lilly (LLY) just reported that its investigational pill, orforglipron, achieved every main and secondary goal in two late-stage clinical trials for type 2 diabetes. The data showed better blood ...
Over the past decade, Eli Lilly (LLY) has grown into the highest-valued company in the healthcare sector by market ...
This Chevy engine powered some of the world's highest-mileage vehicles over the years, and it keeps on hauling decade after decade.
LONDON,ENGLAND - MAY 30: A photo illustration of a Mounjaro pen on May 30 2025 in London, England. Mounjaro is a treatment for weight loss and type 2 diabetes. (Photo by Peter Dazeley via Getty Images ...
Eli Lilly stock (NYSE: LLY) should be on your radar. Here’s why – it is presently trading within the support range ($688 – $761), price points from which it has previously bounced significantly. Over ...
The shares of pharmaceutical giant Eli Lilly (LLY) are falling 5% today after the company preannounced lower-than-expected fourth-quarter revenue. The firm estimated that it had generated Q4 sales of ...
InvestorsHub on MSN
Ally Financial Inc. shares climb as Q3 profit more than doubles, beating estimates
Ally Financial Inc. (NYSE:ALLY) saw its stock rise 2.70% in pre-market trading on Friday after the company posted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback